TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
8.45
-0.07 (-0.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $7.75 million as of April 28, 2026. Its market cap has decreased by -12.99% in one year.
Market Cap
7.75M
Enterprise Value
-10.20M
1-Year Change
-12.99%
Ranking
Category
Stock Price
$8.45
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $7.75M, a decrease of -83.81%. That is a compound annual growth rate of -31.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 7.75M | 23.72% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 8.16M |
| PharmaCyte Biotech | 8.12M |
| Processa Pharmaceuticals | 7.93M |
| Aptorum Group | 7.66M |
| BioAtla | 7.61M |
| GridAI Technologies | 7.58M |
| Indaptus Therapeutics | 7.53M |
| Immuron | 7.28M |